Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02596087 · ClinicalTrials.gov registry record · NA

Improving Quality by Maintaining Accurate Problems in the EHR

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
2,386
Enrollment target

NCT02596087 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,386 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02596087, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
2,386 participants
Enrollment target

Study Summary

The overall goal of the IQ-MAPLE project is to improve the quality of care provided to patients with several heart, lung and blood conditions by facilitating more accurate and complete problem list documentation. In the first aim, the investigators will design and validate a series of problem inference algorithms, using rule-based techniques on structured data in the electronic health record (EHR) and natural language processing on unstructured data. Both of these techniques will yield candidate problems that the patient is likely to have, and the results will be integrated. In Aim 2, the investigators will design clinical decision support interventions in the EHRs of the four study sites to alert physicians when a candidate problem is detected that is missing from the patient's problem list - the clinician will then be able to accept the alert and add the problem, override the alert, or ignore it entirely. In Aim 3, the investigators will conduct a randomized trial and evaluate the effect of the problem list alert on three endpoints: alert acceptance, problem list addition rate and clinical quality.

Interventions

  • OTHER Problem List Suggestion

Trial Details

FieldValue
Enrollment Target 2,386 participants
Start Date 2016-04
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT02596087

The ClinicalTrials.gov registry entry for NCT02596087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,386 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Problem List Suggestion is the first listed.

NCT02596087 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02596087 about?

NCT02596087 is a clinical study titled "Improving Quality by Maintaining Accurate Problems in the EHR". The overall goal of the IQ-MAPLE project is to improve the quality of care provided to patients with several heart, lung and blood conditions by facilitating more accurate and complete problem list documentation. In the first aim, the investigators will design and validate a series of problem infere...

What is the current status of trial NCT02596087?

This trial is currently completed. It is a NA study. The enrollment target is 2,386 participants. The study started on 2016-04.

What interventions are being tested in trial NCT02596087?

The interventions under investigation include: Problem List Suggestion (OTHER).

Who is sponsoring clinical trial NCT02596087?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.